Valneva (NasdaqGS:VALN) Q3 2025 Earnings Call November 20, 2025 09:00 AM ET Speaker2Good day, and thank you for standing by. Welcome to the Valneva 9 Month 2025 Financial Results Conference Call and Webcast. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question-and-answer session. To ask a question during the session, please press star 1 and 1 on your telephone. You will then hear an automated message advising your hand is raised. To withdraw yo ...

Moderna (NasdaqGS:MRNA) 2025 Analyst Day November 20, 2025 09:00 AM ET Speaker2Good morning, good afternoon. Welcome to Moderna's headquarters. Thank you so much for taking the time today to be with us in person or to be with us online. Welcome to Moderna 2025 Analyst Day. As you know, our mission is really the North Star of this company. We want to work together with all our stakeholders to deliver the greatest possible impact to people through mRNA medicine. If you think about the near term, our strategy ...

American Public Education (NasdaqGS:APEI) 2025 Investor Day November 20, 2025 09:00 AM ET Speaker0All right, can I ask everyone please to take their seats? All right. I am so excited to welcome all of you to our APEI 2025 Investor Day. Can someone join David in this table over here? He's all by himself over here. There are so many of you I've had the good fortune of meeting in person, but I feel like I've met almost all of you because we've had Zooms for a long time. It is surprising sometimes when you real ...

Financial Data and Key Metrics Changes - The stockholders approved the proposal to grant discretionary authority to the Board of Directors for a reverse stock split within a range of 1-for-2 to a maximum of 1-for-10, indicating a strategic move to potentially enhance share value [12][13][14] - The company successfully ratified the selection of M&K CPAs as the independent registered public accounting firm for the fiscal year ending December 31, 2025, ensuring compliance and transparency in financial reporting [15] Business Line Data and Key Metrics Changes - The amendment to the 2022 equity incentive plan to increase the number of shares authorized for issuance to 5 million was approved, which may impact employee compensation and retention strategies [14] Market Data and Key Metrics Changes - The approval of the issuance of shares to Streeterville Capital, LLC, in prepaid financing transactions that may collectively equal or exceed 20% of the issued and outstanding shares indicates a significant capital raise strategy [14] Company Strategy and Development Direction - The company is pursuing a reincorporation from Delaware to Nevada, which may provide more favorable business regulations and tax benefits [13] Management's Comments on Operating Environment and Future Outlook - Management did not provide specific comments on the operating environment or future outlook during this meeting, focusing instead on the proposals and voting results Other Important Information - The meeting concluded with the election of seven directors, ensuring continuity in governance and strategic direction [12][13] Summary of Q&A Session - There were no recorded questions or answers during the meeting, as the focus was primarily on the proposals and voting outcomes

Shoe Carnival (NasdaqGS:SCVL) Q3 2026 Earnings Call November 20, 2025 09:00 AM ET Speaker1Good morning and welcome to Shoe Carnival's third quarter 2025 earnings conference call. All lines have been placed on mute to prevent any background noise. After the speaker's remarks, there will be a question-and-answer session. If you would like to ask a question during this time, simply press star followed by the number one on your telephone keypad. If you would like to withdraw your question, press star one again. ...

CareDx (NasdaqGM:CDNA) FY Conference November 20, 2025 09:00 AM ET Company ParticipantsKeith Kennedy - COOJohn Hanna - CEOConference Call ParticipantsMason Carrico - Research AnalystMason CarricoWelcome, everyone, to day three of the Stephens Conference. I'm Mason Carrico. I'm the med tech and diagnostics analyst here. Excited to have CareDx with us today. We've got John Hanna, CEO, and Keith Kennedy, COO. Thank you, guys, for making it.John HannaThanks for having us, Mason. We really appreciate it.Keith Ke ...

ACI Worldwide (NasdaqGS:ACIW) FY Conference November 20, 2025 09:00 AM ET Company ParticipantsJohn Kraft - Head of Investor RelationsBobby Leibrock - CFOChuck Nabhan - Managing DirectorConference Call ParticipantsNone - AnalystChuck NabhanGood morning, everyone. Everybody hear me okay? All right. My name is Chuck Nabhan. I cover the payments and fintech space at Stephens. Pleased to host Bobby Leibrock, the CFO of ACI, as well as John Kraft, Head of Investor Relations. For those that aren't familiar with th ...

Insulet (NasdaqGS:PODD) 2025 Investor Day November 20, 2025 09:00 AM ET Company ParticipantsCarolyn Sleeth - Head of US BusinessDavid Roman - Managing DirectorNone - Unknown Speaker 9None - Unknown Speaker 3None - Unknown Speaker 7None - Unknown Speaker 11Eric Benjamin - COOClaire Trachtman - VP of Investor RelationsNone - Unknown Speaker 4None - Unknown Speaker 5Manoj Raghunandanan - Chief Growth OfficerTrang Ly - Chief Medical OfficerNone - Unknown Speaker 8None - Unknown Speaker 6None - Unknown Speaker 2 ...

American Public Education (NasdaqGS:APEI) 2025 Investor Day November 20, 2025 09:00 AM ET Company ParticipantsKarmela Gaffney - CMODwayne Bertotto - COORaj Sharma - Managing DirectorEd Codispoti - CFOMatt Filek - Senior Equity ResearchNuno Fernandes - PresidentMark Arnold - PresidentNone - Company RepresentativeJasper Bibb - VPConference Call ParticipantsTom White - Senior Equity Research AnalystEric Martinuzzi - Senior Research AnalystScott Schnabel - AnalystGriffin Boss - Equity Research AnalystLuke Horto ...

November 2025 Investor Presentation Fiscal 2025 Fourth Quarter and Year End Financial Results Forward-Looking Statements and Non-GAAP Measures Forward-Looking Statements This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. NJR cautions readers that the assumptions forming the basis for forward-looking statement ...